Nick received his PhD in pharmaceutical science from Rutgers University in 2012 with research focused on drug delivery utilizing nanotechnology. During his industrial postdoctoral training in CSPC biotech he worked on expression, production, purification and characterization of human growth hormone (HGH) and Enterokinase light chain. He is currently working as a Visiting Investigator in Dr. Michelle Bradbury’s Lab where his work includes translational research using Cornell dots conjugated with targeting ligands, analytical characterization of antibody conjugated nanoparticle and a drug conjugated nanoparticle.